Mesenchymal stem cells (UC-MSC) are characterized by their multipotency, immunosuppression and hypo-immunogenicity. MSC transplant raises hope for treatment of various diseases including graft versus host disease, myocardial infarction and autoimmune disease. Human umbilical cord tissue is an abundant and accessible resource of MSC with no ethical concern, which takes great advantage in clinical application. We are dedicated in banking of clinical grade umbilical cord MSC (UC-MSC) and large-scale manufacturing of cell injection to insure the safety, efficiency and reproduction of UC-MSC as a cell drug.